# Benjamin Kong

> Benjamin Kong is a seed investor in San Francisco backing Biotechnology and Blockchain. See 17 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Location: San Francisco, United States
- Total investments: 17
- Last investment: May 2020
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/benjamin-kong-92037ab/

Benjamin Kong is a Canadian investor backing early-stage transformative startups in Space, Biotech, Life Sciences, AI, Longevity, and Blockchain. He started investing in 2014 and has since funded over 50 startups and 3 VC funds. Recent early stage investments include Luminous Computing, Orbit Fab, Relativity Space, Swarm, TransAstra, RadianAerospace, Volumetric, OISIN, OncoSenX, Aegis BioDefense, Excision Biotherapeutics, MAIA Biotechnology, Ashvattha Therapeutics, ZenGo, Coinbase, Algorand, Oasis Labs, Arweave.

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $750k–$8.7M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 5 | 29% |
| Blockchain | 4 | 24% |
| Cryptocurrency | 3 | 18% |
| FinTech | 2 | 12% |
| Aerospace | 2 | 12% |

25 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 7 | 41% |
| Funding Round | 3 | 18% |
| Pre-Seed | 2 | 12% |
| Series A | 1 | 6% |
| Series C | 1 | 6% |

7 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 11 | 65% |
| Israel | 1 | 6% |
| United Kingdom | 1 | 6% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Radian | Radian Aerospace (Radian) is disrupting the aerospace industry with a next generation aerospace vehicle that is the world’s first fully reusable horizontal takeoff and landing, single-stage to orbit spaceplane, delivering people and light cargo to low earth orbit (LEO) and multiple terrestrial destinations with aircraft-like operations. |  | Pre-Seed | May 01, 2020 |  |
| Radian | Radian Aerospace (Radian) is disrupting the aerospace industry with a next generation aerospace vehicle that is the world’s first fully reusable horizontal takeoff and landing, single-stage to orbit spaceplane, delivering people and light cargo to low earth orbit (LEO) and multiple terrestrial destinations with aircraft-like operations. |  | Convertible Note | May 01, 2020 |  |
| Excision BioTherapeutics | Excision BioTherapeutics is a private company focused on developing advanced gene-editing therapeutics to address the medical need for the treatment of life-threatening diseases caused by viral infections. They develop gene-editing medicines that eradicate or disrupt viral genes in human patients. Their mission is to advance gene-editingtherapeutics for our indications into safe and efficacious medicines that will greatly improve the lives of infected individuals around the world. |  |  | Dec 20, 2019 |  |
| Excision BioTherapeutics | Excision BioTherapeutics is a private company focused on developing advanced gene-editing therapeutics to address the medical need for the treatment of life-threatening diseases caused by viral infections. They develop gene-editing medicines that eradicate or disrupt viral genes in human patients. Their mission is to advance gene-editingtherapeutics for our indications into safe and efficacious medicines that will greatly improve the lives of infected individuals around the world. | $750K | Seed | Dec 20, 2019 |  |
| Volumetric | Volumetric is an advanced biomaterials and biofabrication company that develops a 3D bioprinting platform intended to create materials with living cells with applications in biomaterials, cancer research, and human organ replacements. | $1.8M | Seed | Nov 19, 2019 |  |
| MAIA Biotech | MAIA Biotechnology is dedicated to developing targeted cancer therapies with novel mechanisms of action that are intended to meaningfully improve and extend the lives of patients with cancer. ​ Telomerase is present in 90% of human cancer cells and contributes significantly to proliferative abilities and immortality of cancer cells. It is eitherabsent or shows low activity in normal cells. THIO(6-thio-dG) is recognized by telomerase and incorporated into telomeres. Once incorporated, it compromises telomere structure and function, leading to ‘uncapping’ of the chromosome ends resulting in rapid tumor cell death. | $1.5M | Seed | Oct 09, 2019 |  |
| Relativity Space | Relativity Space is an aerospace company that designs, develops, and builds 3D-printed rockets. a vertically integrated technology platform, Relativity is at the forefront of an inevitable shift toward software-defined manufacturing by fusing 3D printing, artificial intelligence, and autonomous robotics. It offers a radically simplified supplychain, building a rocket with 100x fewer parts in less than 60 days. Relativity Space is backed by leading investors including Bond, Tribe Capital, Playground Global, Y Combinator, Social Capital, and Mark Cuban. | $140M | Series C | Oct 01, 2019 |  |
| Zengo | ZenGo is a developer of a non-custodial digital currency wallet designed to make the global crypto economy more accessible. |  | Seed | Sep 05, 2019 |  |
| OncoSenX | OncoSenX is a developer of transient gene therapies designed for solid tumors. The company's therapy delivers plasmid DNA with a novel lipid nanoparticle that selectively kills cancerous cells based on their transcriptional activity, providing cancer patients, doctors and medical care professionals with a less invasive and more preciseintervention for this complex and devastating disease. | $3M | Pre-Seed | Jul 08, 2019 |  |
| Coinbase | Coinbase is an online platform for digital currency transactions, enabling merchants, consumers, and traders to buy, sell, and store cryptocurrencies. The company provides Bitcoin wallet services, allowing users to manage digital assets and conduct transactions. Coinbase offers merchant payment processing tools, supporting businesses in integratingcryptocurrency payments. It facilitates secure digital currency exchanges, assisting users in navigating blockchain-based financial transactions. | $300M | Series E | Oct 30, 2018 |  |

10 of 17 investments shown.

## Co-investors
- [Helios Capital](https://shizune.co/investors/profile/helios-capital-1131) — VC Fund, 3 deals together
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund, 2 deals together
- [Bixin Ventures](https://shizune.co/investors/profile/bixin-ventures) — VC Fund, 2 deals together
- [Dekrypt Capital](https://shizune.co/investors/profile/dekrypt-capital) — VC Fund, 2 deals together
- [HCVC](https://shizune.co/investors/profile/hardwareclub) — VC Fund, 2 deals together
- [Kosmos Ventures](https://shizune.co/investors/profile/kosmos-capital) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [OurCrowd](https://shizune.co/investors/profile/ourcrowd) — VC Fund
- [Entrée Capital](https://shizune.co/investors/profile/entree-capital) — VC Fund
- [Pitango VC](https://shizune.co/investors/profile/pitango-venture-capital) — VC Fund

## Featured in investor lists
- [Biotech Angel Investors](https://shizune.co/investors/biotech-angel-investors)
- [Biotech Angel Investors in United States](https://shizune.co/investors/biotech-angel-investors-united-states)
- [Biotechnology Angel Investors](https://shizune.co/investors/biotechnology-angel-investors)
- [Payments Angel Investors in Israel](https://shizune.co/investors/payments-angel-investors-israel)
- [Web3 Angel Investors in United Kingdom](https://shizune.co/investors/web3-angel-investors-united-kingdom)
- [Financial Services Angel Investors in Israel](https://shizune.co/investors/financial-services-angel-investors-israel)

## FAQ

### What does Benjamin Kong invest in?

Benjamin Kong invests primarily in Biotechnology, Blockchain and Cryptocurrency startups, most often at Seed and Funding Round stage. Most of the 17 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Benjamin Kong's check size?

Benjamin Kong typically joins rounds of $750k–$8.7M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Benjamin Kong participates in.

### When did Benjamin Kong last invest?

The most recent investment recorded for Benjamin Kong closed in May 2020. Shizune tracks 17 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co